Pilongo, Rudilyn T.

HRN: 26-64-10  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/22/2025
CEFUROXIME 1.5GM (VIAL)
03/22/2025
03/26/2025
IV
1.5gms
Q8hrs X 5 Days
S/P STAT CS With BTL
Waiting Final Action 
03/22/2025
CEFUROXIME 500MG (TAB)
03/22/2025
03/28/2025
PO
500mg
BID
S/P STAT CS With BTL
Waiting Final Action 
03/22/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
03/22/2025
03/26/2025
IV
500mg
Q8hrs
S/P STAT CS With BTL
Waiting Final Action 
03/25/2025
CEFUROXIME 500MG (TAB)
03/25/2025
03/31/2025
PO
500mg
BID
Intraabdominal Post Op Wound
Waiting Final Action 
03/25/2025
METRONIDAZOLE 500MG (TAB)
03/25/2025
03/31/2025
PO
500mg
BID
Intraabdominal Post Op Wound
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: